Global Vaccine for Influenza Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Vaccine for Influenza Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Vaccine for Influenza by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Vaccine for Influenza by Country/Region, 2017, 2022 & 2028

2.2 Vaccine for Influenza Segment by Type

2.2.1 Trivalent Influenza Vaccine

2.2.2 Quadrivalent Influenza Vaccine

2.3 Vaccine for Influenza Sales by Type

2.3.1 Global Vaccine for Influenza Sales Market Share by Type (2017-2022)

2.3.2 Global Vaccine for Influenza Revenue and Market Share by Type (2017-2022)

2.3.3 Global Vaccine for Influenza Sale Price by Type (2017-2022)

2.4 Vaccine for Influenza Segment by Application

2.4.1 For Children (6 months to 3 years)

2.4.2 For Adults and Children over 3 years

2.5 Vaccine for Influenza Sales by Application

2.5.1 Global Vaccine for Influenza Sale Market Share by Application (2017-2022)

2.5.2 Global Vaccine for Influenza Revenue and Market Share by Application (2017-2022)

2.5.3 Global Vaccine for Influenza Sale Price by Application (2017-2022)

3 Global Vaccine for Influenza by Company

3.1 Global Vaccine for Influenza Breakdown Data by Company

3.1.1 Global Vaccine for Influenza Annual Sales by Company (2020-2022)

3.1.2 Global Vaccine for Influenza Sales Market Share by Company (2020-2022)

3.2 Global Vaccine for Influenza Annual Revenue by Company (2020-2022)

3.2.1 Global Vaccine for Influenza Revenue by Company (2020-2022)

3.2.2 Global Vaccine for Influenza Revenue Market Share by Company (2020-2022)

3.3 Global Vaccine for Influenza Sale Price by Company

3.4 Key Manufacturers Vaccine for Influenza Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Vaccine for Influenza Product Location Distribution

3.4.2 Players Vaccine for Influenza Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Vaccine for Influenza by Geographic Region

4.1 World Historic Vaccine for Influenza Market Size by Geographic Region (2017-2022)

4.1.1 Global Vaccine for Influenza Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Vaccine for Influenza Annual Revenue by Geographic Region

4.2 World Historic Vaccine for Influenza Market Size by Country/Region (2017-2022)

4.2.1 Global Vaccine for Influenza Annual Sales by Country/Region (2017-2022)

4.2.2 Global Vaccine for Influenza Annual Revenue by Country/Region

4.3 Americas Vaccine for Influenza Sales Growth

4.4 APAC Vaccine for Influenza Sales Growth

4.5 Europe Vaccine for Influenza Sales Growth

4.6 Middle East & Africa Vaccine for Influenza Sales Growth

5 Americas

5.1 Americas Vaccine for Influenza Sales by Country

5.1.1 Americas Vaccine for Influenza Sales by Country (2017-2022)

5.1.2 Americas Vaccine for Influenza Revenue by Country (2017-2022)

5.2 Americas Vaccine for Influenza Sales by Type

5.3 Americas Vaccine for Influenza Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Vaccine for Influenza Sales by Region

6.1.1 APAC Vaccine for Influenza Sales by Region (2017-2022)

6.1.2 APAC Vaccine for Influenza Revenue by Region (2017-2022)

6.2 APAC Vaccine for Influenza Sales by Type

6.3 APAC Vaccine for Influenza Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Vaccine for Influenza by Country

7.1.1 Europe Vaccine for Influenza Sales by Country (2017-2022)

7.1.2 Europe Vaccine for Influenza Revenue by Country (2017-2022)

7.2 Europe Vaccine for Influenza Sales by Type

7.3 Europe Vaccine for Influenza Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Vaccine for Influenza by Country

8.1.1 Middle East & Africa Vaccine for Influenza Sales by Country (2017-2022)

8.1.2 Middle East & Africa Vaccine for Influenza Revenue by Country (2017-2022)

8.2 Middle East & Africa Vaccine for Influenza Sales by Type

8.3 Middle East & Africa Vaccine for Influenza Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Vaccine for Influenza

10.3 Manufacturing Process Analysis of Vaccine for Influenza

10.4 Industry Chain Structure of Vaccine for Influenza

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Vaccine for Influenza Distributors

11.3 Vaccine for Influenza Customer

12 World Forecast Review for Vaccine for Influenza by Geographic Region

12.1 Global Vaccine for Influenza Market Size Forecast by Region

12.1.1 Global Vaccine for Influenza Forecast by Region (2023-2028)

12.1.2 Global Vaccine for Influenza Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Vaccine for Influenza Forecast by Type

12.7 Global Vaccine for Influenza Forecast by Application

13 Key Players Analysis

13.1 Sanofi

13.1.1 Sanofi Company Information

13.1.2 Sanofi Vaccine for Influenza Product Offered

13.1.3 Sanofi Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Main Business Overview

13.1.5 Sanofi Latest Developments

13.2 CSL

13.2.1 CSL Company Information

13.2.2 CSL Vaccine for Influenza Product Offered

13.2.3 CSL Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 CSL Main Business Overview

13.2.5 CSL Latest Developments

13.3 GSK

13.3.1 GSK Company Information

13.3.2 GSK Vaccine for Influenza Product Offered

13.3.3 GSK Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 GSK Main Business Overview

13.3.5 GSK Latest Developments

13.4 Mylan

13.4.1 Mylan Company Information

13.4.2 Mylan Vaccine for Influenza Product Offered

13.4.3 Mylan Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Mylan Main Business Overview

13.4.5 Mylan Latest Developments

13.5 Hulan Bio

13.5.1 Hulan Bio Company Information

13.5.2 Hulan Bio Vaccine for Influenza Product Offered

13.5.3 Hulan Bio Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Hulan Bio Main Business Overview

13.5.5 Hulan Bio Latest Developments

13.6 AstraZeneca

13.6.1 AstraZeneca Company Information

13.6.2 AstraZeneca Vaccine for Influenza Product Offered

13.6.3 AstraZeneca Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 AstraZeneca Main Business Overview

13.6.5 AstraZeneca Latest Developments

13.7 CCBIO

13.7.1 CCBIO Company Information

13.7.2 CCBIO Vaccine for Influenza Product Offered

13.7.3 CCBIO Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 CCBIO Main Business Overview

13.7.5 CCBIO Latest Developments

14 Research Findings and Conclusion

Table 1. Vaccine for Influenza Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Vaccine for Influenza Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Trivalent Influenza Vaccine

Table 4. Major Players of Quadrivalent Influenza Vaccine

Table 5. Global Vaccine for Influenza Sales by Type (2017-2022) & (K Units)

Table 6. Global Vaccine for Influenza Sales Market Share by Type (2017-2022)

Table 7. Global Vaccine for Influenza Revenue by Type (2017-2022) & ($ million)

Table 8. Global Vaccine for Influenza Revenue Market Share by Type (2017-2022)

Table 9. Global Vaccine for Influenza Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Vaccine for Influenza Sales by Application (2017-2022) & (K Units)

Table 11. Global Vaccine for Influenza Sales Market Share by Application (2017-2022)

Table 12. Global Vaccine for Influenza Revenue by Application (2017-2022)

Table 13. Global Vaccine for Influenza Revenue Market Share by Application (2017-2022)

Table 14. Global Vaccine for Influenza Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Vaccine for Influenza Sales by Company (2020-2022) & (K Units)

Table 16. Global Vaccine for Influenza Sales Market Share by Company (2020-2022)

Table 17. Global Vaccine for Influenza Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Vaccine for Influenza Revenue Market Share by Company (2020-2022)

Table 19. Global Vaccine for Influenza Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Vaccine for Influenza Producing Area Distribution and Sales Area

Table 21. Players Vaccine for Influenza Products Offered

Table 22. Vaccine for Influenza Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Vaccine for Influenza Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Vaccine for Influenza Sales Market Share Geographic Region (2017-2022)

Table 27. Global Vaccine for Influenza Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Vaccine for Influenza Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Vaccine for Influenza Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Vaccine for Influenza Sales Market Share by Country/Region (2017-2022)

Table 31. Global Vaccine for Influenza Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Vaccine for Influenza Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Vaccine for Influenza Sales by Country (2017-2022) & (K Units)

Table 34. Americas Vaccine for Influenza Sales Market Share by Country (2017-2022)

Table 35. Americas Vaccine for Influenza Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Vaccine for Influenza Revenue Market Share by Country (2017-2022)

Table 37. Americas Vaccine for Influenza Sales by Type (2017-2022) & (K Units)

Table 38. Americas Vaccine for Influenza Sales Market Share by Type (2017-2022)

Table 39. Americas Vaccine for Influenza Sales by Application (2017-2022) & (K Units)

Table 40. Americas Vaccine for Influenza Sales Market Share by Application (2017-2022)

Table 41. APAC Vaccine for Influenza Sales by Region (2017-2022) & (K Units)

Table 42. APAC Vaccine for Influenza Sales Market Share by Region (2017-2022)

Table 43. APAC Vaccine for Influenza Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Vaccine for Influenza Revenue Market Share by Region (2017-2022)

Table 45. APAC Vaccine for Influenza Sales by Type (2017-2022) & (K Units)

Table 46. APAC Vaccine for Influenza Sales Market Share by Type (2017-2022)

Table 47. APAC Vaccine for Influenza Sales by Application (2017-2022) & (K Units)

Table 48. APAC Vaccine for Influenza Sales Market Share by Application (2017-2022)

Table 49. Europe Vaccine for Influenza Sales by Country (2017-2022) & (K Units)

Table 50. Europe Vaccine for Influenza Sales Market Share by Country (2017-2022)

Table 51. Europe Vaccine for Influenza Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Vaccine for Influenza Revenue Market Share by Country (2017-2022)

Table 53. Europe Vaccine for Influenza Sales by Type (2017-2022) & (K Units)

Table 54. Europe Vaccine for Influenza Sales Market Share by Type (2017-2022)

Table 55. Europe Vaccine for Influenza Sales by Application (2017-2022) & (K Units)

Table 56. Europe Vaccine for Influenza Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Vaccine for Influenza Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Vaccine for Influenza Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Vaccine for Influenza Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Vaccine for Influenza Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Vaccine for Influenza Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Vaccine for Influenza Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Vaccine for Influenza Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Vaccine for Influenza Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Vaccine for Influenza

Table 66. Key Market Challenges & Risks of Vaccine for Influenza

Table 67. Key Industry Trends of Vaccine for Influenza

Table 68. Vaccine for Influenza Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Vaccine for Influenza Distributors List

Table 71. Vaccine for Influenza Customer List

Table 72. Global Vaccine for Influenza Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Vaccine for Influenza Sales Market Forecast by Region

Table 74. Global Vaccine for Influenza Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Vaccine for Influenza Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Vaccine for Influenza Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Vaccine for Influenza Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Vaccine for Influenza Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Vaccine for Influenza Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Vaccine for Influenza Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Vaccine for Influenza Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Vaccine for Influenza Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Vaccine for Influenza Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Vaccine for Influenza Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Vaccine for Influenza Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Vaccine for Influenza Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Vaccine for Influenza Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Vaccine for Influenza Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Vaccine for Influenza Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Vaccine for Influenza Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Vaccine for Influenza Revenue Market Share Forecast by Application (2023-2028)

Table 92. Sanofi Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors

Table 93. Sanofi Vaccine for Influenza Product Offered

Table 94. Sanofi Vaccine for Influenza Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Sanofi Main Business

Table 96. Sanofi Latest Developments

Table 97. CSL Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors

Table 98. CSL Vaccine for Influenza Product Offered

Table 99. CSL Vaccine for Influenza Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. CSL Main Business

Table 101. CSL Latest Developments

Table 102. GSK Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors

Table 103. GSK Vaccine for Influenza Product Offered

Table 104. GSK Vaccine for Influenza Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. GSK Main Business

Table 106. GSK Latest Developments

Table 107. Mylan Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors

Table 108. Mylan Vaccine for Influenza Product Offered

Table 109. Mylan Vaccine for Influenza Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Mylan Main Business

Table 111. Mylan Latest Developments

Table 112. Hulan Bio Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors

Table 113. Hulan Bio Vaccine for Influenza Product Offered

Table 114. Hulan Bio Vaccine for Influenza Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Hulan Bio Main Business

Table 116. Hulan Bio Latest Developments

Table 117. AstraZeneca Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors

Table 118. AstraZeneca Vaccine for Influenza Product Offered

Table 119. AstraZeneca Vaccine for Influenza Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. AstraZeneca Main Business

Table 121. AstraZeneca Latest Developments

Table 122. CCBIO Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors

Table 123. CCBIO Vaccine for Influenza Product Offered

Table 124. CCBIO Vaccine for Influenza Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. CCBIO Main Business

Table 126. CCBIO Latest Developments

List of Figures

Figure 1. Picture of Vaccine for Influenza

Figure 2. Vaccine for Influenza Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Vaccine for Influenza Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Vaccine for Influenza Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Vaccine for Influenza Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Trivalent Influenza Vaccine

Figure 10. Product Picture of Quadrivalent Influenza Vaccine

Figure 11. Global Vaccine for Influenza Sales Market Share by Type in 2021

Figure 12. Global Vaccine for Influenza Revenue Market Share by Type (2017-2022)

Figure 13. Vaccine for Influenza Consumed in For Children (6 months to 3 years)

Figure 14. Global Vaccine for Influenza Market: For Children (6 months to 3 years) (2017-2022) & (K Units)

Figure 15. Vaccine for Influenza Consumed in For Adults and Children over 3 years

Figure 16. Global Vaccine for Influenza Market: For Adults and Children over 3 years (2017-2022) & (K Units)

Figure 17. Global Vaccine for Influenza Sales Market Share by Application (2017-2022)

Figure 18. Global Vaccine for Influenza Revenue Market Share by Application in 2021

Figure 19. Vaccine for Influenza Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Vaccine for Influenza Revenue Market Share by Company in 2021

Figure 21. Global Vaccine for Influenza Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Vaccine for Influenza Revenue Market Share by Geographic Region in 2021

Figure 23. Global Vaccine for Influenza Sales Market Share by Region (2017-2022)

Figure 24. Global Vaccine for Influenza Revenue Market Share by Country/Region in 2021

Figure 25. Americas Vaccine for Influenza Sales 2017-2022 (K Units)

Figure 26. Americas Vaccine for Influenza Revenue 2017-2022 ($ Millions)

Figure 27. APAC Vaccine for Influenza Sales 2017-2022 (K Units)

Figure 28. APAC Vaccine for Influenza Revenue 2017-2022 ($ Millions)

Figure 29. Europe Vaccine for Influenza Sales 2017-2022 (K Units)

Figure 30. Europe Vaccine for Influenza Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Vaccine for Influenza Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Vaccine for Influenza Revenue 2017-2022 ($ Millions)

Figure 33. Americas Vaccine for Influenza Sales Market Share by Country in 2021

Figure 34. Americas Vaccine for Influenza Revenue Market Share by Country in 2021

Figure 35. United States Vaccine for Influenza Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Vaccine for Influenza Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Vaccine for Influenza Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Vaccine for Influenza Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Vaccine for Influenza Sales Market Share by Region in 2021

Figure 40. APAC Vaccine for Influenza Revenue Market Share by Regions in 2021

Figure 41. China Vaccine for Influenza Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Vaccine for Influenza Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Vaccine for Influenza Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Vaccine for Influenza Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Vaccine for Influenza Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Vaccine for Influenza Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Vaccine for Influenza Sales Market Share by Country in 2021

Figure 48. Europe Vaccine for Influenza Revenue Market Share by Country in 2021

Figure 49. Germany Vaccine for Influenza Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Vaccine for Influenza Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Vaccine for Influenza Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Vaccine for Influenza Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Vaccine for Influenza Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Vaccine for Influenza Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Vaccine for Influenza Revenue Market Share by Country in 2021

Figure 56. Egypt Vaccine for Influenza Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Vaccine for Influenza Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Vaccine for Influenza Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Vaccine for Influenza Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Vaccine for Influenza Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Vaccine for Influenza in 2021

Figure 62. Manufacturing Process Analysis of Vaccine for Influenza

Figure 63. Industry Chain Structure of Vaccine for Influenza

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles